Biodesix Inc (NASDAQ: BDSX) kicked off on Tuesday, up 6.60% from the previous trading day, before settling in for the closing price of $0.28. Over the past 52 weeks, BDSX has traded in a range of $0.17-$2.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 69.26%. While this was happening, its average annual earnings per share was recorded 26.46%. With a float of $69.36 million, this company’s outstanding shares have now reached $146.44 million.
Let’s determine the extent of company efficiency that accounts for 273 employees. In terms of profitability, gross margin is 78.38%, operating margin of -43.71%, and the pretax margin is -54.28%.
Biodesix Inc (BDSX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Biodesix Inc is 52.68%, while institutional ownership is 36.42%. The most recent insider transaction that took place on May 16 ’25, was worth 1,070,000. In this transaction Director of this company bought 4,000,000 shares at a rate of $0.27, taking the stock ownership to the 20,194,935 shares. Before that another transaction happened on May 19 ’25, when Company’s Director bought 723,239 for $0.34, making the entire transaction worth $246,624. This insider now owns 20,918,174 shares in total.
Biodesix Inc (BDSX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 26.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.97% during the next five years compared to 69.26% growth over the previous five years of trading.
Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators
Take a look at Biodesix Inc’s (BDSX) current performance indicators. Last quarter, stock had a quick ratio of 2.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Biodesix Inc (BDSX)
Looking closely at Biodesix Inc (NASDAQ: BDSX), its last 5-days average volume was 0.87 million, which is a drop from its year-to-date volume of 4.59 million. As of the previous 9 days, the stock’s Stochastic %D was 55.26%.
During the past 100 days, Biodesix Inc’s (BDSX) raw stochastic average was set at 14.41%, which indicates a significant decrease from 80.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0223 in the past 14 days, which was lower than the 0.0648 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3378, while its 200-day Moving Average is $0.9682. However, in the short run, Biodesix Inc’s stock first resistance to watch stands at $0.3065. Second resistance stands at $0.3191. The third major resistance level sits at $0.3344. If the price goes on to break the first support level at $0.2786, it is likely to go to the next support level at $0.2633. Should the price break the second support level, the third support level stands at $0.2507.
Biodesix Inc (NASDAQ: BDSX) Key Stats
The company with the Market Capitalisation of 43.09 million has total of 146,563K Shares Outstanding. Its annual sales at the moment are 71,320 K in contrast with the sum of -42,930 K annual income. Company’s last quarter sales were recorded 17,960 K and last quarter income was -11,100 K.
